Delivery Order SPE2DR25D1002-SPE2DR26FGH8N
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,893.18 to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12-year and older formulation, 0.3 mL syringes) with a completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a...
- The Defense Logistics Agency awarded a $3,810.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine product (12 years and up, 0.3 mL syringes) with an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract was issued on June 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a $12,703.00 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine doses (0.3mL syringes for ages 12 and up). This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performs the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a $10,060.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and up, 0.3mL syringes) with an ultimate completion date of November 6, 2025. This is a non-set-aside competitive award issued on October 16, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,175.75 to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 (12 years and up) vaccine in 0.3 mL syringes, with an ultimate completion date of May 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under DLA's medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,218.80 to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 (12Y UP) vaccine in 0.3mL syringes. The contract was competitively awarded without set-aside designation under firm fixed-price terms, with an ultimate completion date of November 12, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and up, 0.3mL syringes) with a ceiling value of $1,893.18 and an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,270.30 on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, identified as COMIRNATY 2024-25 (12 years and up) at 0.3 milliliters, represents a single-dose vaccine supply for military healthcare operations. The contract was competitively awarded with no set-aside provisions and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $12,621.20 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine product (12-year-old formulation, 0.3mL syringes) with an ultimate completion date of October 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed from the vendor's location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,460.55 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 20, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle supporting federal...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGH8NDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,221.90 to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine product (12 years and up, 0.3 mL syringes) with an ultimate completion date of November 13, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on October 22, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical support vehicle for military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies vaccines, medications, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling military pharmaceutical needs through competitively awarded firm fixed price delivery orders. The DLA Troop Support Medical IDC represents a comprehensive global pharmaceutical support program enabling the contractor to supply specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/22/25 |